Primary record
sotuletinib
- CAS
- 953769-46-5
- PubChem CID
- 46184986
- SMILES
- CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)N[C@@H]4CCCC[C@H]4O
- Molecular Formula
- C20H22N4O3S
- Molecular Weight
- 398.488
- Exact Mass
- 398.1413
- InChI
- InChI=1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1
- InChIKey
- ADZBMFGQQWPHMJ-RHSMWYFYSA-N
- LogP
- 3.5586
- TPSA
- 96.37
Names and synonyms
- sotuletinib
- BLZ945
- BLZ-945
- 953769-46-5
- UNII-7W3V82OQ0P
- 7W3V82OQ0P
- BLZ 945
- RefChem:120669
- SOTULETINIB [INN]
- MFCD28142668
- D08NDE
- MIDODRINEHYDROCHLORIDE
- CHEMBL4227505
- C20H22N4O3S
- CSF-1R INHIBITOR BLZ945
- GTPL8250
- orb1301056
- P-BLZ945
- SCHEMBL2676695
- BLZ 945 [WHO-DD]
- SCHEMBL29368442
- SCHEMBL29368661
- 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide
- CSF-1R inhibitor (bone cancer)
- EX-A817
- SYN1197
- ADZBMFGQQWPHMJ-RHSMWYFYSA-N
- GLXC-90408
- KS-00001D1X
- 3193AH